IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY RATES IN PATENTS WITH ISCHEMIC CARDIOMYOPATHY SELECTED FOR PRIMARY PREVENTION DEVICES ON THE BASIS OF LEFT VENTRICULAR EJECTION FRACTION AND ELECTROPHYSIOLOGY TESTING
Keyword(s):
2016 ◽
Vol 22
(2)
◽
pp. 125-132
◽
2016 ◽
Vol 17
(4)
◽
pp. 245-255
◽
2013 ◽
Vol 6
(2)
◽
pp. 257-264
◽
Keyword(s):
2013 ◽
Vol 167
(4)
◽
pp. 1360-1365
◽
2013 ◽
Vol 111
(8)
◽
pp. 1175-1179
◽
2014 ◽
Vol 172
(1)
◽
pp. 253-254
◽
2017 ◽
Vol 29
(2)
◽
pp. 119-129
Keyword(s):